| Genomic classification of cutaneous melanoma R Akbani, KC Akdemir, B áArman Aksoy, M Albert, A Ally, SB Amin, ... Cell 161 (7), 1681-1696, 2015 | 2790 | 2015 |
| Loss of PTEN promotes resistance to T cell–mediated immunotherapy W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ... Cancer discovery 6 (2), 202-216, 2016 | 1431 | 2016 |
| Loss of IFN-γ pathway genes in tumor cells as a mechanism of resistance to anti-CTLA-4 therapy J Gao, LZ Shi, H Zhao, J Chen, L Xiong, Q He, T Chen, J Roszik, ... Cell 167 (2), 397-404. e9, 2016 | 1262 | 2016 |
| Integrative analysis identifies four molecular and clinical subsets in uveal melanoma AG Robertson, J Shih, C Yau, EA Gibb, J Oba, KL Mungall, JM Hess, ... Cancer cell 32 (2), 204-220. e15, 2017 | 877 | 2017 |
| Comprehensive and integrated genomic characterization of adult soft tissue sarcomas AJ Lazar, MD McLellan, MH Bailey, CA Miller, EL Appelbaum, MG Cordes, ... Cell 171 (4), 950-965, 2017 | 867 | 2017 |
| Integrated molecular analysis of tumor biopsies on sequential CTLA-4 and PD-1 blockade reveals markers of response and resistance W Roh, PL Chen, A Reuben, CN Spencer, PA Prieto, JP Miller, ... Science translational medicine 9 (379), eaah3560, 2017 | 783 | 2017 |
| Integrative genomic analysis of cholangiocarcinoma identifies distinct IDH-mutant molecular profiles F Farshidfar, S Zheng, MC Gingras, Y Newton, J Shih, AG Robertson, ... Cell reports 18 (11), 2780-2794, 2017 | 675 | 2017 |
| A comprehensive pan-cancer molecular study of gynecologic and breast cancers AC Berger, A Korkut, RS Kanchi, AM Hegde, W Lenoir, W Liu, Y Liu, ... Cancer cell 33 (4), 690-705. e9, 2018 | 588 | 2018 |
| Increased tumor glycolysis characterizes immune resistance to adoptive T cell therapy T Cascone, JA McKenzie, RM Mbofung, S Punt, Z Wang, C Xu, ... Cell metabolism 27 (5), 977-987. e4, 2018 | 512 | 2018 |
| Dietary fiber and probiotics influence the gut microbiome and melanoma immunotherapy response CN Spencer, JL McQuade, V Gopalakrishnan, JA McCulloch, M Vetizou, ... Science 374 (6575), 1632-1640, 2021 | 505 | 2021 |
| The genomic landscape and clinical relevance of A-to-I RNA editing in human cancers L Han, L Diao, S Yu, X Xu, J Li, R Zhang, Y Yang, HMJ Werner, ... Cancer cell 28 (4), 515-528, 2015 | 496 | 2015 |
| mTORC2 promotes tumorigenesis via lipid synthesis Y Guri, M Colombi, E Dazert, SK Hindupur, J Roszik, S Moes, P Jenoe, ... Cancer cell 32 (6), 807-823. e12, 2017 | 386 | 2017 |
| Loss of PTEN promotes resistance to T cell-mediated immunotherapy. Cancer Discov. 2016; 6: 202–216. doi: 10.1158/2159-8290 W Peng, JQ Chen, C Liu, S Malu, C Creasy, MT Tetzlaff, C Xu, ... CD-15-0283.[Europe PMC free article][Abstract][CrossRef][Google Scholar], 2018 | 309 | 2018 |
| NLRC5/MHC class I transactivator is a target for immune evasion in cancer S Yoshihama, J Roszik, I Downs, TB Meissner, S Vijayan, B Chapuy, ... Proceedings of the National Academy of Sciences 113 (21), 5999-6004, 2016 | 259 | 2016 |
| Mechanisms of nuclear content loading to exosomes A Yokoi, A Villar-Prados, PA Oliphint, J Zhang, X Song, P De Hoff, ... Science advances 5 (11), eaax8849, 2019 | 233 | 2019 |
| Bioengineering T cells to target carbohydrate to treat opportunistic fungal infection PR Kumaresan, PR Manuri, ND Albert, S Maiti, H Singh, T Mi, J Roszik, ... Proceedings of the National Academy of Sciences 111 (29), 10660-10665, 2014 | 202 | 2014 |
| Immuno-genomic landscape of osteosarcoma CC Wu, HC Beird, J Andrew Livingston, S Advani, A Mitra, S Cao, ... Nature communications 11 (1), 1008, 2020 | 190 | 2020 |
| Hypoxia-driven immunosuppressive metabolites in the tumor microenvironment: new approaches for combinational immunotherapy Y Li, SP Patel, J Roszik, Y Qin Frontiers in immunology 9, 1591, 2018 | 177 | 2018 |
| Beyond BRAFV600: clinical mutation panel testing by next-generation sequencing in advanced melanoma AE Siroy, GM Boland, DR Milton, J Roszik, S Frankian, J Malke, L Haydu, ... Journal of Investigative Dermatology 135 (2), 508-515, 2015 | 164 | 2015 |
| Exploiting the neoantigen landscape for immunotherapy of pancreatic ductal adenocarcinoma P Bailey, DK Chang, MA Forget, FAS Lucas, HA Alvarez, C Haymaker, ... Scientific reports 6 (1), 35848, 2016 | 161 | 2016 |
